Initial results of a randomized phase III trial of high dose image guided radiation with or without androgen deprivation therapy for intermediate-risk prostate cancer.
Cancer Treatment and Research Communications（2019）
Abstract
Low toxicity and minimal temporary bother as measured by EPIC and IPSS were seen in both arms. ADT was well-tolerated and associated with temporary changes.
MoreTranslated text
Key words
Prostate cancer,Prostatic neoplasms,Androgen deprivation,Image guidance,Brachytherapy,Radiotherapy,IMRT,phase III,randomized
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined